In fact, loss of SIRT3 in human CLL cells contributes to cancer progression via hyperacetylation of the metabolic enzymes isocitrate dehydrogenase (IDH2) and superoxide dismutase 2 (SOD2). The gene discussed is SOD2; the disease is cancer.